Bioceres Crop Solutions Reports Fiscal First Quarter 2023 Financial and Operational Results
Revenues increased 71% compared to 1Q22 pro forma numbers 1Q23 Adjusted EBITDA nearly doubled YoY, reaching $73 million on an LTM basis after excluding HB4 pre-launch costs Announced agreement with Syngenta Seedcare supporting inoculant growth internationally November 09, 2022 07:08 PM Eastern Standard Time Source: https://www.businesswire.com ROSARIO, Argentina–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a …